Moxilex L Eye Drops

Moxilex L Moxifloxacin & Loteprednol Etabonate Eye Drops

Moxilex L is an ophthalmic combination formulation containing Moxifloxacin 0.5% w/v and Loteprednol Etabonate 0.5% w/v. It combines a fluoroquinolone antibiotic with a corticosteroid to provide antibacterial activity and control of inflammation in selected ocular conditions.

Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic that works by inhibiting bacterial enzymes involved in DNA replication, helping prevent the growth and multiplication of susceptible bacteria.

Loteprednol Etabonate is a corticosteroid that helps reduce ocular inflammation, redness, swelling and associated discomfort in steroid-responsive eye conditions.

The combination may be prescribed when an ocular condition involves bacterial infection together with inflammation, particularly where both antibacterial and anti-inflammatory treatment are clinically appropriate.

Composition

Moxifloxacin Hydrochloride IP equivalent to Moxifloxacin 0.5% w/v

Loteprednol Etabonate 0.5% w/v

Uses of Moxilex L Eye Drops

Moxilex L may be prescribed for selected ocular infections associated with inflammation.

It may be used in conditions involving:

• Bacterial conjunctivitis associated with inflammation
• Selected inflammatory eye infections
• Post-operative ocular inflammation where bacterial infection or risk of infection is present
• Selected cases of blepharitis associated with bacterial infection and inflammation
• Other steroid-responsive ocular conditions where antibacterial therapy is clinically appropriate

The exact indication should be determined by a qualified ophthalmologist or healthcare professional.

How Moxilex L Works

Moxifloxacin provides antibacterial activity against susceptible organisms by interfering with bacterial DNA replication through inhibition of DNA gyrase and topoisomerase IV.

Loteprednol Etabonate helps suppress the inflammatory response in steroid-responsive ocular conditions.

The combination therefore provides complementary antibacterial and anti-inflammatory action when both types of treatment are clinically required.

Key Product Features

• Moxifloxacin 0.5% w/v
• Loteprednol Etabonate 0.5% w/v
• Ophthalmic antibiotic and corticosteroid combination
• Broad-spectrum antibacterial activity
• Helps control ocular inflammation
• Helps reduce redness and swelling associated with inflammation
• Used for selected eye infections with inflammation
• Ophthalmic suspension formulation
• 5 ml presentation

Product Information

Brand Name: Moxilex L

Composition: Moxifloxacin 0.5% w/v + Loteprednol Etabonate 0.5% w/v

Dosage Form: Ophthalmic Suspension / Eye Drops

Route of Administration: Ophthalmic

Therapeutic Class: Ophthalmic Antibiotic + Corticosteroid

Pharmacological Class: Fluoroquinolone Antibiotic + Corticosteroid

Packing: 5 ml

Important Information

Moxilex L is a prescription ophthalmic medicine and should be used only under the supervision of a qualified ophthalmologist or healthcare professional.

Because the formulation contains a corticosteroid, inappropriate or prolonged use may increase the risk of complications such as increased intraocular pressure, glaucoma, cataract formation and delayed corneal healing.

Ophthalmic corticosteroids may mask or worsen certain eye infections. The medicine should therefore be used only when corticosteroid therapy is considered appropriate by the prescribing healthcare professional.

The combination should not be used for untreated fungal, mycobacterial or certain viral infections of the eye unless specifically directed by an ophthalmologist.

Patients with glaucoma, a history of increased intraocular pressure, corneal disease, recurrent eye infections or other significant ocular conditions should inform their healthcare professional before use.

If eye pain, vision changes, worsening redness, severe irritation or other concerning symptoms develop, medical evaluation should be sought.

Dosage and Administration

The dosage, frequency and duration of treatment should be determined by the prescribing ophthalmologist according to the patient's condition and clinical response.

Shake the ophthalmic suspension well before use.

Use the eye drops exactly as directed by the healthcare professional.

Avoid touching the dropper tip to the eye, eyelids, fingers or other surfaces to prevent contamination.

Storage

Store according to the storage conditions specified on the approved product label.

Keep the container tightly closed when not in use.

Protect from excessive heat, moisture and direct light where applicable.

Keep out of reach of children.

Product Summary

Moxilex L combines Moxifloxacin 0.5% w/v and Loteprednol Etabonate 0.5% w/v in an ophthalmic formulation designed to provide antibacterial and anti-inflammatory action.

Moxifloxacin helps control susceptible bacterial infection, while Loteprednol Etabonate helps reduce inflammation in steroid-responsive ocular conditions.

The combination should be used under appropriate ophthalmic supervision when both antibacterial and anti-inflammatory treatment are clinically indicated.